IMMUNE THROMBOCYTOPENIC PURPURA
Clinical trials for IMMUNE THROMBOCYTOPENIC PURPURA explained in plain language.
Never miss a new study
Get alerted when new IMMUNE THROMBOCYTOPENIC PURPURA trials appear
Sign up with your email to follow new studies for IMMUNE THROMBOCYTOPENIC PURPURA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a cholesterol drug and antioxidant help treat a rare bleeding disorder?
Disease control Not yet recruitingThis trial investigates whether combining atorvastatin (a cholesterol-lowering drug), N-acetyl-L-cysteine (an antioxidant), and romiplostim (a platelet-boosting drug) can help adults with immune thrombocytopenia (ITP) who no longer respond to steroids. The goal is to see if this …
Matched conditions: IMMUNE THROMBOCYTOPENIC PURPURA
Phase: NA • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
AI tool aims to predict heart risks in rare blood disorder patients
Knowledge-focused Not yet recruitingThis study is creating an AI tool to help doctors decide the best heart treatment for people who have both immune thrombocytopenia (ITP) and coronary artery disease. Researchers will look at past patient data to build the tool, then test it on 600 new patients. The goal is to bet…
Matched conditions: IMMUNE THROMBOCYTOPENIC PURPURA
Sponsor: Xiao Hui Zhang • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC
-
Fatigue in ITP: is poor fitness the hidden culprit?
Knowledge-focused Not yet recruitingThis study looks at whether young people (ages 8–25) with chronic immune thrombocytopenic purpura (ITP) have lower aerobic fitness than healthy peers. Fatigue is a major problem for many with ITP, and the researchers want to see if it's linked to a 'vicious cycle' of being less a…
Matched conditions: IMMUNE THROMBOCYTOPENIC PURPURA
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC